Cargando…
Elimination In Vivo of Developing T Cells by Natural Killer Cells
Natural killer cells gauge the absence of self class I MHC on susceptible target cells by means of inhibitory receptors such as members of the Ly49 family. To initiate killing by natural killer cells, a lack of inhibitory signals must be accompanied by the presence of activating ligands on the targe...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194238/ https://www.ncbi.nlm.nih.gov/pubmed/14568980 http://dx.doi.org/10.1084/jem.20030918 |
_version_ | 1782147658210607104 |
---|---|
author | Schott, Eckart Bonasio, Roberto Ploegh, Hidde L. |
author_facet | Schott, Eckart Bonasio, Roberto Ploegh, Hidde L. |
author_sort | Schott, Eckart |
collection | PubMed |
description | Natural killer cells gauge the absence of self class I MHC on susceptible target cells by means of inhibitory receptors such as members of the Ly49 family. To initiate killing by natural killer cells, a lack of inhibitory signals must be accompanied by the presence of activating ligands on the target cell. Although natural killer cell–mediated rejection of class I MHC–deficient bone marrow (BM) grafts is a matter of record, little is known about the targeting in vivo of specific cellular subsets by natural killer cells. We show here that development of class I MHC–negative thymocytes is delayed as a result of natural killer cell toxicity after grafting of a class I MHC–positive host with class I MHC–negative BM. Double positive thymocytes that persist in the presence of natural killer cells display an unusual T cell receptor–deficient phenotype, yet nevertheless give rise to single positive thymocytes and yield mature class I MHC–deficient lymphocytes that accumulate in the class I MHC–positive host. The resulting class I MHC–deficient CD8 T cells are functional and upon activation remain susceptible to natural killer cell toxicity in vivo. Reconstitution of class I MHC–deficient BM precursors with H2-K(b) by retroviral transduction fully restores normal thymic development. |
format | Text |
id | pubmed-2194238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21942382008-04-11 Elimination In Vivo of Developing T Cells by Natural Killer Cells Schott, Eckart Bonasio, Roberto Ploegh, Hidde L. J Exp Med Article Natural killer cells gauge the absence of self class I MHC on susceptible target cells by means of inhibitory receptors such as members of the Ly49 family. To initiate killing by natural killer cells, a lack of inhibitory signals must be accompanied by the presence of activating ligands on the target cell. Although natural killer cell–mediated rejection of class I MHC–deficient bone marrow (BM) grafts is a matter of record, little is known about the targeting in vivo of specific cellular subsets by natural killer cells. We show here that development of class I MHC–negative thymocytes is delayed as a result of natural killer cell toxicity after grafting of a class I MHC–positive host with class I MHC–negative BM. Double positive thymocytes that persist in the presence of natural killer cells display an unusual T cell receptor–deficient phenotype, yet nevertheless give rise to single positive thymocytes and yield mature class I MHC–deficient lymphocytes that accumulate in the class I MHC–positive host. The resulting class I MHC–deficient CD8 T cells are functional and upon activation remain susceptible to natural killer cell toxicity in vivo. Reconstitution of class I MHC–deficient BM precursors with H2-K(b) by retroviral transduction fully restores normal thymic development. The Rockefeller University Press 2003-10-20 /pmc/articles/PMC2194238/ /pubmed/14568980 http://dx.doi.org/10.1084/jem.20030918 Text en Copyright © 2003, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Schott, Eckart Bonasio, Roberto Ploegh, Hidde L. Elimination In Vivo of Developing T Cells by Natural Killer Cells |
title | Elimination In Vivo of Developing T Cells by Natural Killer Cells |
title_full | Elimination In Vivo of Developing T Cells by Natural Killer Cells |
title_fullStr | Elimination In Vivo of Developing T Cells by Natural Killer Cells |
title_full_unstemmed | Elimination In Vivo of Developing T Cells by Natural Killer Cells |
title_short | Elimination In Vivo of Developing T Cells by Natural Killer Cells |
title_sort | elimination in vivo of developing t cells by natural killer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194238/ https://www.ncbi.nlm.nih.gov/pubmed/14568980 http://dx.doi.org/10.1084/jem.20030918 |
work_keys_str_mv | AT schotteckart eliminationinvivoofdevelopingtcellsbynaturalkillercells AT bonasioroberto eliminationinvivoofdevelopingtcellsbynaturalkillercells AT ploeghhiddel eliminationinvivoofdevelopingtcellsbynaturalkillercells |